Meeting
2018 Gastrointestinal Cancers Symposium
Association of genetic variations within the PD-L2 immune checkpoint gene with outcome in stage II and III colon cancer.
Authors
Martin D. Berger
USC Keck School of Medicine, Los Angeles, CA
Martin D. Berger , Inti Zlobec , Dongyun Yang , Shu Cao , Yu Sunakawa , Satoshi Matsusaka , Viktor H. Koelzer , Daniel Inderbitzin , Yan Ning , Satoshi Okazaki , Yuji Miyamoto , Mitsukuni Suenaga , Marta Schirripa , Shivani Soni , Alberto Puccini , Ryuma Tokunaga , Madiha Naseem , Wu Zhang , Alessandro Lugli , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 626)
DOI
10.1200/JCO.2018.36.4_suppl.626
Abstract #
626
Poster Bd #
D11
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Treg infiltration and the expression of immune checkpoints associated with T cell exhaustion in AML.
First Author: Patrick Williams
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Prognostic value of the expression of immunomodulatory targets in surgically resected lung adenocarcinoma.
First Author: Kazuya Takamochi
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita